Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

New hay fever remedy available for the fall allergy season

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

Topical clotrimazole for the treatment of actinic keratosis

Sep. 27, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

Use of bisaramil in oxidative stress-related conditions

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...